Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies

Posaconazole is a triazole antifungal used to prevent invasive fungal infections (IFIs) in patients receiving chemotherapy or haemotopoietic stem cell transplantation. Due to highly variable bioavailability of the oral suspension formulation, a delayed-release tablet was developed which showed impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Leclerc, Elisabeth, Combarel, David, Uzunov, Madalina, Leblond, Véronique, Funck-Brentano, Christian, Zahr, Noël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785994/
https://www.ncbi.nlm.nih.gov/pubmed/29374234
http://dx.doi.org/10.1038/s41598-018-20136-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785994/
https://www.ncbi.nlm.nih.gov/pubmed/29374234
http://dx.doi.org/10.1038/s41598-018-20136-3

Ejemplares similares